Analytical Data
-
Gene name
FAM131A
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N- His-GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6UXB0
-
Expression Region
1-281aa
-
Molecular Weight
61.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM131A, or Family with Sequence Similarity 131 Member A, is a relatively new protein that has garnered attention due to its potential role in cellular processes and human health. Research indicates that FAM131A may be involved in various signaling pathways, including those associated with immune responses, cellular proliferation, and apoptosis. Its expression has been reported in various tissues, suggesting a wide range of physiological functions. Advances in recombinant protein technology have afforded researchers the ability to produce and study FAM131A in detail. By generating recombinant FAM131A, scientists aim to elucidate its structure-function relationship, investigate its interaction with other cellular molecules, and assess its potential implications in diseases, particularly in immunological disorders and cancer. Understanding the functional dynamics of FAM131A could provide insights into its role as a biomarker for specific diseases or as a target for therapeutic interventions. The increasing interest in FAM131A reflects a broader trend in molecular biology where identifying and understanding the roles of lesser-studied proteins can lead to significant advancements in biomedicine. Overall, the exploration of FAM131A offers a promising avenue for enhancing our understanding of complex biological systems and devising novel strategies for disease management.
